Immunosuppressive therapy.
D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use; D006505:Hepatitis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate